Aug 23 2017

Wililam Garvin, Shareholder in the firm's FDA & Biotechnology section, and Michael Strazzella, Practice Group Leader of Buchanan's Federal Government Relations practice and head of Buchanan's Washington D.C. office, presented "2017-2018 Federal Update Forecast" at Specialty Pharma Association's Regulatory Workshop.